{"id":"NCT03594110","sponsor":"Boehringer Ingelheim","briefTitle":"EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)","officialTitle":"A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-01-31","primaryCompletion":"2022-07-05","completion":"2024-07-02","firstPosted":"2018-07-20","resultsPosted":"2023-07-27","lastUpdate":"2025-07-20"},"enrollment":6609,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Kidney Disease"],"interventions":[{"type":"DRUG","name":"Empagliflozin","otherNames":[]},{"type":"DRUG","name":"Matching placebo","otherNames":[]}],"arms":[{"label":"Empagliflozin 10 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death versus placebo on top of standard of care in patients with pre-existing chronic kidney disease. After completion of the interventional part of the study (primary study completion) a subset of participants will be followed up in a post-trial observational (non-interventional) manner for cardio-renal outcomes (estimated study completion date).","primaryOutcome":{"measure":"Interventional Part: Time to First Occurrence of Kidney Disease Progression or Cardiovascular Death ('as Adjudicated')","timeFrame":"From the day of randomisation to the day of the final follow-up visit in the interventional part of the trial, up to 1136 days.","effectByArm":[{"arm":"Placebo","deltaMin":8.96,"sd":null},{"arm":"Empagliflozin 10 mg","deltaMin":6.85,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":16},"locations":{"siteCount":240,"countries":["United States","Canada","China","Germany","Italy","Japan","Malaysia","United Kingdom"]},"refs":{"pmids":["40686671","40658498","40179340","39453837","38770818","38082486","38061372","38061371","36331190","35472672","34074889","32778748","31939531"],"seeAlso":["https://www.mystudywindow.com"]},"adverseEventsSummary":{"seriousAny":{"events":1167,"n":3305},"commonTop":["Gout"]}}